← all vendors
1Platform4
AI score: 67 / 100
Viable with known tradeoffs
Biotech and pharma manufacturing operations platform
Type: growing (ops / MRP) · Tech: modern · Budget: SMB friendly ($10k–$70k/yr)
Core verticals: medical / bioscience, plastics / chemicals / batch
Functions: manufacturing / MES, quality, reporting / BI
1Platform4 is a cloud manufacturing operations platform built for biotech and pharmaceutical manufacturers. Covers electronic batch records (eBR), master batch records (MBR), production scheduling, equipment management, and FDA 21 CFR Part 11 compliance workflows. Designed for GxP-regulated production environments.
Purpose-built for GxP-regulated biotech and pharma production — electronic batch records, 21 CFR Part 11 e-signatures, and deviation management are native features rather than ERP add-ons; smaller vendor scale is the primary risk for regulated manufacturer due diligence.
AI score breakdown — 6 dimensions
SMB implementability 25%65
Cloud SaaS with direct vendor-led validation support for GxP environments. FDA 21 CFR Part 11 compliance documentation provided. Typically 3–6 months for validated deployment.
Purpose fit 20%80
Strong GxP manufacturing depth: electronic batch records, master batch records, formulation management, equipment qualification tracking, deviation and CAPA management, and audit trail for regulatory submissions.
Tech modernity 20%75
Cloud-native, modern web interface. 21 CFR Part 11 compliant e-signatures. API integrations with LIMS and other regulated system platforms.
Documentation quality 15%65
Good compliance-specific documentation. Regulatory validation support documentation available. Direct vendor support during implementation.
Real user sentiment 10%62
Positive reviews from biotech and pharma manufacturers. Limited G2 corpus given niche market.
TCO transparency 10%52
Contact for pricing. SaaS model. Budget tier 2–3 for regulated biotech implementation.
validate / explore this score:
Perplexity
ChatGPT
Claude
Google